Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-011513
Filing Date
2025-04-29
Accepted
2025-04-29 17:05:52
Documents
2
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form3-04292025_090448.html 3  
1 form3-04292025_090448.xml 3 11040
2 ex24-04292025_090448.htm EX-24 6533
  Complete submission text file 0001415889-25-011513.txt   19156
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Issuer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REPARE THERAPEUTICS INC. 7171 FREDERICK BANTING, BLD. 2, STE. 270 ST-LAURENT Quebec, Canada H4S 1Z9
Business Address
Alves Sandra Isabelle Barros (Reporting) CIK: 0002065621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39335 | Film No.: 25889086